Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boehringer Ingelheim Announces FDA Approval of Spiriva® Respimat® for the Maintenance Treatment of COPD
Boehringer Ingelheim Announces FDA Approval of Spiriva® Respimat® for the Maintenance Treatment of COPD
Boehringer Ingelheim Announces FDA Approval of Spiriva® Respimat® for the Maintenance Treatment of COPD
Submitted by
admin
on September 25, 2014 - 8:58am
Source:
Marketwatch
News Tags:
Boehringer Ingelheim
FDA
Spiriva
COPD
Headline:
Boehringer Ingelheim Announces FDA Approval of Spiriva® Respimat® for the Maintenance Treatment of COPD
Do Not Allow Advertisers to Use My Personal information
